Cell Expansion Market Report 2026

Cell Expansion Market Overview

• Cell Expansion market size has reached to $32.31 billion in 2025 • Expected to grow to $69.42 billion in 2030 at a compound annual growth rate (CAGR) of 16.6% • Growth Driver: Government Funding Surge Boosts Cell Expansion Market Growth • Market Trend: Technological Advancements Fuel Innovation In Cell Expansion Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Expansion Market?

The cell expansion refers to a cellular process used to create new cell wall material. Its purpose is to control the loosening of the wall and allow it to stretch and expand in the area. Cell-wall-associated proteins from the expansion family play an essential role in this process. The main types of cell expansion are mammalian, microbial, and others. The mammalian type of cell expansion is used for cultivating cells from mammals. It is the process of cultivating cells from mammals in flasks or bioreactors in vitro. The products included are consumables, reagents, media, serums, disposables, and instruments that are applied in biopharmaceuticals, tissue culture and engineering, vaccine production, drug development, gene therapy, cancer research, stem cell research, and others. It is used by biopharmaceutical and biotechnology companies, research institutes, cell banks, and others.

What Is The Cell Expansion Market Growth Forecast?

The cell expansion market size is expected to see rapid growth in the next few years. It will grow to $69.42 billion in 2030 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to increasing demand for cell and gene therapies, rising investments in large-scale biologics production, expansion of regenerative medicine pipelines, growing focus on cost-efficient scale-up, increasing adoption of closed-system expansion technologies. Major trends in the forecast period include increasing adoption of single-use cell expansion systems, rising demand for scalable cell culture platforms, growing use of serum-free expansion media, expansion of automated bioreactor systems, enhanced focus on process standardization.

Global Cell Expansion Market Segmentation

1) By Cell Type: Mammalian, Microbial, Other Cell Types 2) By Product: Consumables, Reagents, Media, Serum, Disposables, Instruments 3) By Application: Biopharmaceuticals, Tissue Culture And Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research, Other Applications 4) By End-User: Biopharmaceutical And Biotechnology Companies, Research Institutes, Cell Banks, Other End-Users Subsegments: 1) By Mammalian: Adherent Cells, Suspension Cells, Stem Cells 2) By Microbial: Bacterial Cells, Yeast Cells, Fungal Cells 3) By Other Cell Types: Plant Cells, Insect Cells, Hybridoma Cells

What Is The Driver Of The Cell Expansion Market?

Increasing government funding for research and development is expected to propel the growth of the cell expansion market going forward. Government funding refers to money provided by a government to pay for a particular purpose. Increasing government funding for research and development in cell expansion plays a pivotal role in fostering innovation, driving advancements in cell-based therapies, and accelerating the progress of regenerative medicine. For instance, in September 2023, the National Cancer Institute, a US-based government agency, received a budget from the United States Congress of $7.3 billion in fiscal year 2023, which is a $408 million increase over 2022. Therefore, increasing government funding for research and development is driving the growth of the cell expansion industry.

Key Players In The Global Cell Expansion Market

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd.

Global Cell Expansion Market Trends and Insights

Major companies in the cell expansion market are prioritizing advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to enhance the efficiency and scalability of cell production for therapeutic applications. PluriCDMO provides large-scale, automated cell therapy manufacturing using a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development through clinical trials. For instance, in January 2024, Pluristem Therapeutics Inc., an Israel-based biotechnology company, launched a new business division named PluriCDMO that will offer cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The new division includes a 47,000-ft2 good manufacturing practice (GMP) cell therapy production facility. Through this new division, Pluri will offer services relating to early preclinical development through late-stage clinical trials and commercialization.

What Are Latest Mergers And Acquisitions In The Cell Expansion Market?

In March 2023, Sartorius AG, a Germany-based pharmaceutical company, acquired Polyplus-Transfection SA for $2.36 billion. This acquisition is expected to help Sartorius AG strengthen its supply of cell and gene therapy companies, broadening its portfolio for gene therapies and gene-modified cell therapies. Polyplus-Transfection SA is a France-based biotechnology company that supports gene and cell therapy, biologics manufacturing, and life science research.

Regional Outlook

North America was the largest region in the cell expansion market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Expansion Market?

The cell expansion market includes revenues earned by entities by providing bioreactors and automated cell expansion systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Expansion Market Report 2026?

The cell expansion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell expansion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.